GS0401: Manufacturing services for others in the area of pharmaceutical drug delivery systems, namely, continuous release, pulsatile release, extended release, sustained release, taste masked release, and delayed release systems; clinical manufacturing of drug formulations for others to support clinical trials; fabrication and preparation of active pharmaceutical ingredients for others; technology scale-up services for others; and integration of technology into manufacturing processes for others; all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables
D10000: "PARTICLE FABRICATION"
GS0421: Pharmaceutical drug delivery technology development services; pharmaceutical drug delivery technology development services, namely, research and development in the area of pharmaceutical drug delivery systems in the nature of continuous release, pulsatile release, extended release, sustained release, taste masked release, and delayed release systems, consisting of selection of drug formulation and delivery systems to optimize performance of active pharmaceutical ingredients, analytic techniques to test drug formulations, analytic services to detect, identify and quantify drug components, stability testing, physical characterization of drug formulations, in-vitro release testing, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables
Case File Event Statements
5/30/2023 - a year ago
9 - NOTICE OF REGISTRATION CONFIRMATION EMAILEDType:NRCC
5/30/2023 - a year ago
8 - REGISTERED-PRINCIPAL REGISTERType:R.PR
3/14/2023 - a year ago
7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
3/14/2023 - a year ago
6 - PUBLISHED FOR OPPOSITIONType:PUBO
2/22/2023 - a year ago
5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
2/7/2023 - a year ago
4 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
2/6/2023 - a year ago
3 - ASSIGNED TO EXAMINERType:DOCK
4/26/2022 - 2 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS